Agentes poliaminérgicos modulam a reconsolidação da memória de medo em ratos

• Autor(a) principal: Ribeiro, Daniela Aymone
• Data de Publicação: 2013
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Manancial - Repositório Digital da UFSM
• Texto Completo: http://repositorio.ufsm.br/handle/1/11216
• topic: Memória; Reconsolidação; Receptor NMDA; Espermidina; Arcaína; Medo condicionado contextual; Memory; Reconsolidation; NMDA receptor; Spermidine; Arcaine; Contextual fear conditioning; CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA

The memory may be studied according with memory's phases, which is acquisition, consolidation and recall. Memories once consolidated, are no more susceptible to interventions, but when reactivated, some of these memories again become labile and vulnerable, and to persist need to have a new stabilization process called reconsolidation. Previous studies described that endogenous polyamines, spermine and spermidine, which bind and modulate the activity of NMDA receptors are involved in memory acquisition and consolidation. However there are no studies showing the effect of these drugs on memory reconsolidation. Accordingly, the aim of this study was investigate the effect of polyamines on fear memory reconsolidation in rats. Male Wistar rats were trained in a fear conditioning apparatus using a 0.4 mA footshock as unconditioned stimulus. Twenty four hours after training, animals were re-exposed to the apparatus in the absence of shock (reactivation session). Immediately after the reactivation session, SPD (1 30 mg/kg, i.p.), the antagonist of the polyamine binding site at the NMDA receptor, arcaine (0.1 10 mg/kg, i.p.) or spermidine plus arcaine were injected, and the animals were tested in the same apparatus 24 h later. Freezing scores at testing were considered a measure of memory. While SPD (3 and 10 mg/kg) improved, arcaine (1 and 10 mg/kg) impaired memory reconsolidation. These drugs had no effect on memory if they were administered in the absence of reactivation, or 6 h after reactivation session. Arcaine (0.1 mg/kg, i.p.) prevented SPD (3 mg/kg)-induced improvement of memory reconsolidation. Accordingly, SPD (1 mg/kg) prevented arcaine (10 mg/kg)-induced impairment of memory reconsolidation. The amnesic effect of arcaine was not reversed by arcaine administration prior to test, ruling out state dependence in this effect. These results suggest that systemic administration of polyamine binding site ligands modulate memory reconsolidation, however further studies are required to elucidate the mechanism by which polyamines modulate memory reconsolidation.